HIV type 1 resistance in kenyan sex workers is not associated with altered cellular susceptibility to HIV type infection or enhanced β- chemokine production

AIDS Research and Human Retroviruses

Volumn 14, Issue 17, 1998, Pages 1521-1530

  Fowke, Keith R ^a   Dong, Tao ^b   Rowland Jones, Sarah L ^b   Oyugi, Julius ^c   Rutherford, W John ^d   Kimani, Joshua ^c   Krausa, Pete ^b   Bwayo, Job ^c   Simonsen, J Neil ^c,d   Shearer, Gene M ^a   Plummer, Francis A ^c,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RANTES;

ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; KENYA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTITUTION;

EID: 18744426566     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.1521     Document Type: Article

References (55)

1. Fauci AS: Resistance to HIV-1 infection: It's in the genes. Nature Med 1996;2:966-967.
2. Travers K, Mboup S, Marlink R, Gueye-Nidaye A, Siby T, Thior I, Traore I, Dieng-Sarr A, Sankale JL, Mullins C, et al.: Natural protection against HIV-1 infection provided by HIV-2. Science 1995;268:1612-1615.
3. Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ, MacDonald KS, Ngugi EN, and Plummer FA: Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996;348:1347-1351.
4. Cohen OJ, Kinter A, and Fauci AS: Host factors in the pathogenesis of HIV disease. Immunol Rev 1997;159:31-48.
5. Paxton WA, Martin SR, Tse D, O'Brien TR, Shumick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, and Koup RA: Relative resistance to HIV-1 infection in CD4 lymphocytes from persons who remain uninfected despite multiple highrisk sexual exposures. Nature Med 1996;3:412-417.
6. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horak R, MacDonald ME, Stuhlmann H, Koup RA, and Landau NR: Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply exposed individuals to HIV-1 infection. Cell 1996;86: 367-377.
7. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, and Lusso P: Identification of RANTES and MIP-1 alpha, and MIP-1 beta as the major HIV-1-suppressive factors produced by CD8+ T cells. Science 1995;270:1811-1815.
8. Lehner T, Wang Y, Cranage M, Bergmeier LA, Mitchell E, Tao L, Hall G, Dennis M, Cook N, Brookes R, Klavinskis L, Jones I, Doyle C, and Ward R: Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Med 1996;2:767-775.
9. Zagury D, Lachgar A, Chams V, Fall LS, Bernard J, Zagury JF, Bizzini B, Gringeri A, Santagostino E, Rappaport J, Feldman M, O'Brien SJ, Burny A, and Gallo RC: C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci USA 1998;95:3857-3861.
10. Clerici M, Giorgi JV, Chou CC, Gudeman VK, Zack JA, Gupta P, Ho HN, Nishanian PG, Berzofsky JA, and Shearer GM: Cell-mediated immune responses to human immunodeficiency virus (HIV-1) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992;165:1012-1019.
11. Cheynier R, Langlade-Demoyen P, Marescot MR, Blanche S, Blondin G, Wain-Hobson S, Griscelli C, Vilmer E, and Plata F: Cytotoxic T lymphocyte responses in the peripheral blood of children born to HIV-1-infected mothers. Eur J Immunol 1993;22: 2211-2217.
12. Langlade-Demoyen P, Ngo-Giang-Guong N, Fercha FL, and Oksenhendler E: Human immunodeficiency virus (HIV-1) Nef-specific cytotoxic T lymphocytes in non-infected heterosexual contacts of HIV-1-infected patients. J Clin Invest 1994;93:1293-1297.
13. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Gallimore A, Corrah T, et al.: HIV-1-specific cytotoxic T-cells in HIV-1-exposed but uninfected Gambian women. Nature Med 1995;1:59-64.
14. Mazzoli S, Trabattoni D, Lo Caputo S, Piconi S, Ble C, Meacci F, Ruzzante S, Salvi A, Semplici F, Longhi R, Fusi ML, Tofani N, Biasin M, Villa ML, Mazzotta F, and Clerici M: HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nature Med 1997;3:1250-1257.
15. Furci L, Scarlatti G, Burastero S, Tambussi G, Colognesi C, Quillent C, Longhi R, Loverro P, Borgonovo B, Gaffi D, Carrow E, Malnati M, Lusso P, Siccardi AG, Lazzarin A, and Beretta : Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele. Exp Med 1997;186:455-160.
16. Fowke KF, Kaul R, Rosenthal K, Oyugi J, Kimani J, Rutherford WJ, Nagelkerke NJD, Ball TB, Bwayo JJ, Simonsen JN, Shearer GM, and Plummer FA: HIV-1 specific cellular immune responses correlate with protection among HIV-1 resistance sex workers. 1998 (submitted).
17. Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa J, Newell H, Blanchard T, Ariyoshi K, Oyugi J, Ngugi E, Bwayo J, MacDonald KS, McMichael AJ, and Plummer FA: Cytotoxic T-cell responses to multiple conserved epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 1998 (in press).
18. MacDonald KS, Fowke KR, Kimani J, Dunand VA, Nagelkerke NJD, Ball TB, Oyuji J, Njagi E, Gaur L, Brunham RC, Wade J, Rowland-Jones SL, Ngugi E, Bwayo JJ, and Plummer FA: The influence of human leukocyte antigens on susceptibility and resistance to HIV-1 in sexually exposed prostitutes. 1998 (submitted).
19. Kaul R, Trabattoni O, Bwayo JJ, Arienti D, Zagliani A, Mwangi FM, Kaiuki C, Ngugi EN, MacDonald KS, Ball TB, Clerici M, and Plummer FA: HIV-1 specific mucosal IgA in a cohort of HIV-1 resistant Kenyan sex workers. AIDS 1998 (submitted).
20. Simonsen JN, Plummer FA, Ngugi EN, Black C, Kreiss JK, Gakinya MN, Waiyaki P, D'Costa LJ, Ndinya-Achola JO, Piot P, et al.: HIV-1 infection among lower socioeconomic strata prostitutes in Nairobi. AIDS 1990;4:139-144.
21. Plummer FA, Simonsen JN, Cameron DW, Ndinya-Achola JO, Kreiss JK, Gakinya MN, Waiyaki P, Cheang M, Piot P, Ronald AR, et al.: Co-factors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991;163: 233-239.
22. Poss M, Gosink J, Thomas E, Kreiss JK, Ndinya-Achola J, Mandaliya K, Bwayo J, and Overbaugh J: Phylogenetic evaluation of Kenyan HIV-1 type 1 isolates. AIDS Res Hum Retroviruses 1997; 13:493-499.
23. Dawood MR, Allan R, Fowke K, Embree J, and Hammond GW: Development of oligonucleotide primers and probes against structural and regulatory genes of human immunodeficiency virus type 1 (HIV-1) and their use for amplification of HIV-1 provirus by using polymerase chain reaction. J Clin Microbiol 1992;30:2279-2283.
24. Zachar V, Goustin AS, Zacharova V, Hager H, Koppelhus U, Womble DD, Liu X, Bambra C, Nyongo A, and Ebbesen P: Genetic polymorphism of envelope V3 region of HIV-1 type 1 subtypes A, C and D from Nairobi, Kenya. AIDS Res Hum Retroviruses 1996;12:75-78.
25. Samson M, Labbe O, Mollereau C, Vassart G, and Parmentier M: Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 1996;35:3362-3367.
26. Combadiere C, Ahuja SK, and Murphy PM: Cloning and functional expression of a human eosinophil CC chemokine receptor. J Biol Chem 1995;270:16491-16494.
27. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, and Markham AF: Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989;17:2503-2516.
28. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA, and Mackay CR: CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997;185:1681-1691.
29. Bleul CC, Wu L, Hoxie JA, Springer TA, and Mackay CR: The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997;94:1925-1930.
30. Koot M, Vos AH, Keet RP, de Goede RE, Dercksen MW, Terpstra FG, Coutinho RA, Miedema F, and Tersmette M: HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992;6:49-54.
31. Zolla-Pazner S, Alving C, Belshe R, Berman P, Burda S, Chigurupati P, Clements ML, Duliege AM, Excler JL, Hioe C, Kahn J, McElrath MJ, Sharpe S, Sinangil F, Steimer K, Walker MC, Wassef N, and Xu S: Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines. J Infect Dis 1997;175:764-774.
32. Cho MW, Lee MK, Carney MC, Berson JF, Doms RW, and Martin MA: Identification of determinants on a dual tropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4. J Virol 1998;72:2509-2515.
33. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane domain, G-protein coupled receptor. Science 1996;272:872-877.
34. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, Ho DD, and Koup RA: The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 1996;2:1240-1243.
35. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, and Parmentier M: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (London) 1996;382:722-725.
36. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, De Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, and Landau NR: Identification of a major coreceptor for primary isolates of HIV-1. Nature (London) 1996;381:661-666.
37. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, and Paxton WA: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR5. Nature (London) 1996;381:667-673.
38. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, and Sodroski J: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
39. Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, and Springer MS: Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med 1996;183: 2349-2354.
40. Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP, Newman W, Gerard C, and Mackay CR: Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 1996;183:2437-2448.
41. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, and O'Brien SJ: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997;277: 959-965.
42. Michael NL, Louie LG, Rohrbaugh AL, Schultz KA, Dayhoff KE, Wang CE, and Sheppard HW. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nature Med 1997;3:1160-1162.
43. Anzala OA, Ball TB, Rostron T, O'Brien SJ, Plummer FA, Smith MW, Dong T, Njagi E, Bwayo JJ, McMichael AJ, and Rowland-Jones SL: CCR2-64I allele and genotype association with delayed AIDS progression in African women. Lancet 1998;351:1632-1633.
44. Baba M, Imai T, Nishimura M, Kakizaki M, Takagi S, Hieshima K, Nomiyama H, and Yoshie O: Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem 1997;272:14893-14898.
45. Nibbs RJ, Wylie SM, Yang J, Landau NR, and Graham GJ: Clining and characterization of a novel promiscuous human beta-chemokine receptor D6. J Biol Chem 1997;272:32078-32083.
46. Jinno A: Identification of the chemokine receptor TER1/CCR8 expressed in brain-derived cells and T cells as a new coreceptor for HIV-1 infection. Biochem Biophys Res Commun 1998;243: 497-502.
47. Zagury D, Lachgar A, Chams V, Fall LS, Bernard J, Zagury JF, Bizzini B, Gringeri A, Santagostino E, Rappaport J, Feldman M, O'Brien SJ, Bumy A, and Gallo RC: C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci USA 1998;95:3857-3861.
48. Aukrust P, Muller F, and Froland SSJ: Circulating levels of RANTES in human immunodeficiency virus type 1 infection: Effect of potent antiretroviral therapy. Infect Dis 1998;177: 1091-1096.
49. Taub DD, Turcovski-Corrales SM, Key ML, Longo DL, and Murphy WJ: Chemokines and T lymphocyte activation. I. Beta chemokines costimulate human T lymphocyte activation in vitro. J Immunol 1996;156:2095-2103.
50. Stevenson M, Stanwick TL, Dempsey MP, and Lamonica CA: HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 1990;9:1551-1560.
51. Price DA, Sewell AK, Dong T, Tan R, Goulder PJ, Rowland-Jones SL, and Phillips RE: Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes. Curr Biol 1998;8: 355-358.
52. Saha K, Bentsman G, Chess L, and Volsky DJ: Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J Virol 1998;72(1):876-881.
53. Pal R, Garizino-demo A, Markham PD, Burns J, Brown M, Gallo RC, and DeVico AL: Inhibition of HIV-1 infection by the beta-chemokine MDC. Science 1977;278:695-698.
54. Mackewicz CE, Blackbourn DJ, and Levy JA: CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci USA 1995;92:2308-2312.
55. Baier M, Werner A, Bannert N, Metzner K, and Kurth R: HIV suppression by interleukin-16. Nature (London) 1995;378:563.